The Evolution of Generics

About Accord

Accord Healthcare is an emerging large-scale provider of generic pharmaceuticals in the United States.  Our U.S. headquarters is in Durham, North Carolina, near the Research Triangle Park (RTP).  Situated in a 7,000 acre pine forest, RTP is one of the largest research parks in the world.  Close to three major research universities, the area provides an unparalleled scientific, regulatory, quality, and commercial talent pool.

Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976.   Selling in over 70 countries, Accord has a vast global presence.  The Accord and Intas networks provide full integration in the functional areas vital to delivering quality excellence and service efficiencies:  API and finished dosage form manufacturing, R & D, clinical program management, and the economies of scale inherent in worldwide distribution. 

Our current U.S. portfolio consists of over 68 FDA approved oral solid and injectable prescription medicines supplied in over 224 dose presentations.   With over 80 ANDAs and NDAs awaiting approval at FDA, and 120 + products in development, Accord is well-positioned to be a leading generic supplier in the U.S. market in the near future. 

Quarter-over-quarter, we consistently accomplish double-digit growth across all metrics:  in dollar sales, scripts filled, and number of units sold.  We have accomplished this while undergoing multiple plant expansions across all of our manufacturing sites. Our solid record of maintaining high quality standards while implementing such tremendous commercial expansion has set us apart in the industry.